Multiplex cell engineering of allogeneic anti-CD19 CAR T-cells with tuned silencing of HLA class I limits rejection by both CD8 T-cells and NK cells

被引:0
|
作者
Sakic, A. [1 ]
Ponsard, B. [1 ]
Mansuy, M. [1 ]
Lanz, I. [1 ]
Blancheteau, V. [1 ]
Marteyn, A. [1 ]
Genolet, Y. [1 ]
Bourrat, B. [1 ]
Turc, A. [1 ]
Cherpin, O. [1 ]
Ilmjarv, S. [1 ]
Roussel-Gervais, A. [1 ]
Alessandrini, M. [1 ]
机构
[1] Antion Biosci, Plan Les Ouates, Switzerland
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P460
引用
收藏
页码:A202 / A202
页数:1
相关论文
共 50 条
  • [31] Immunotargeting insulin reactive CD8 T-cells in diabetes
    Scott, G. S.
    Fishman, S.
    Margalit, A.
    Siew, L. K.
    Chapman, S.
    Wen, L.
    Gross, G.
    Wong, F. S.
    IMMUNOLOGY, 2008, 125 : 123 - 123
  • [33] REJECTION OF RAT SKIN XENOGRAFTS BY EITHER MURINE CD4 OR CD8 T-CELLS
    CLICK, RE
    WEISBERG, D
    WHITE, J
    REICHENBACH, D
    JAMIESON, SW
    TRANSPLANTATION, 1994, 58 (09) : 1020 - 1026
  • [34] Failure of CD4 T-Cells to Respond to Liver-Derived Antigen and to Provide Help to CD8 T-Cells
    Derkow, Katja
    Mueller, Anja
    Eickmeier, Ira
    Seidel, Daniel
    Moreira, Marcos Vicinius Rust
    Kruse, Nils
    Klugewitz, Katja
    Mintern, Justine
    Wiedenmann, Bertram
    Schott, Eckart
    PLOS ONE, 2011, 6 (07):
  • [35] A New Class of Antigen T-Cells That Redirect Bystander T-Cells to CD19 Positive Malignancies
    Velasquez, Mireya Paulina
    Iwahori, Kota
    Kakarla, Sunitha
    Arber, Caroline
    Rodriguez-Cruz, Tania
    Gerken, Claudia
    Song, Xiao-Tong
    Gottschalk, Stephen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S71 - S71
  • [36] DISTINCT FUNCTIONS OF CD8 FOR RESTING AND ACTIVATED CD8+ T-CELLS
    JONSSON, JI
    SCHMIDTULLRICH, R
    BOYCE, NW
    MUNAKATA, T
    SAIZAWA, KJ
    EICHMANN, K
    HIGHLIGHTS OF MODERN BIOCHEMISTRY, VOLS 1-2, 1989, : 1325 - 1332
  • [37] Treatment of SLE with anti-CD19 CAR-T cells
    Ellen F. Carney
    Nature Reviews Nephrology, 2022, 18 : 743 - 743
  • [38] Treatment of aggressive lymphomas with anti-CD19 CAR T cells
    Christopher A. Klebanoff
    Tori N. Yamamoto
    Nicholas P. Restifo
    Nature Reviews Clinical Oncology, 2014, 11 : 685 - 686
  • [39] Treatment of SLE with anti-CD19 CAR-T cells
    Carney, Ellen F.
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (12) : 743 - 743
  • [40] DIFFERENTIAL EXPRESSION OF FAS ANTIGEN AND BCL-2 PROTEIN ON CD4(+) T-CELLS, CD8(+) T-CELLS, AND MONOCYTES
    SHINOHARA, S
    SAWADA, T
    NISHIOKA, Y
    TOHMA, S
    KISAKI, T
    INOUE, T
    ANDO, K
    IKEDA, M
    FUJII, H
    ITO, K
    CELLULAR IMMUNOLOGY, 1995, 163 (02) : 303 - 308